KAPPA BIOSCIENCE
Kappa Bioscience is the pioneer in the development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL brand name. Kappa’s innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction, and a secure supply chain - with unmatched ingredient purity and documentation. Combine... d with other Kappa innovations such as the patented DELTA microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines - Ingredients and services related to Bones, Joints, and Cardiovascular Health - directly and through a network of global distributors. The main products are Vitamin K2 - K2VITAL, Calcified Atlantic Seaweed, and The Bone Health Triangle.
KAPPA BIOSCIENCE
Industry:
Biotechnology Life Science Pharmaceutical Wellness
Founded:
2006-12-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.kappabio.com
Total Employee:
11+
Status:
Active
Contact:
+49 40 6094087 0
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro IPv6 Apple Mobile Web App Capable Pound Sterling Japanese Yen
Similar Organizations
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-01-24 | ppm.Ingredients | ppm.Ingredients acquired by Kappa Bioscience | N/A |
Investors List
SPRINGfondet
SPRINGfondet investment in Venture Round - Kappa Bioscience
Kistefos Venture Capital
Kistefos Venture Capital investment in Venture Round - Kappa Bioscience
Official Site Inspections
http://www.kappabio.com Semrush global rank: 4.48 M Semrush visits lastest month: 2.42 K
- Host name: dd28812.kasserver.com
- IP address: 85.13.147.64
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Kappa Bioscience"
Get in touch with the Kappa team! | Kappa
Alternatively you can write us an email to [email protected] About Kappa: Kappa Bioscience AS was founded in Oslo, Norway in 2006 when a brilliant scientist discovered the synthesis of pure, all-bioactive vitamin K2 MK-7, an …See details»
Kappa Team – how we work | Kappa
About Kappa. Kappa Bioscience AS was founded in Oslo, Norway, in 2006 when a brilliant scientist discovered the synthesis of pure, all-bioactive vitamin K2 MK-7.See details»
Kappa Bioscience - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +49 40 6094087 0 Kappa Bioscience is the pioneer in the development and production of the only synthetic and biologically active all …See details»
Kappa Bioscience, a Balchem company | LinkedIn
Doingitright.kappabio.com 24 1 Comment Like Comment Share Kappa Bioscience, a Balchem company 3,967 followers 2mo Report this post Back to School Time! ⏰It’s time to keep …See details»
Kappa Bioscience - Verdane
Kappabio.com LinkedIn Kappa Bioscience is a pioneer and innovator within the production of nutraceutical ingredients – primarily of vitamin K2, which plays a key role in improving heart, …See details»
Balchem Corporation Signs Definitive Agreement to Acquire …
June 14, 2022. Balchem Corporation has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human …See details»
Kappa Bioscience - Products, Competitors, Financials, Employees ...
On June 14th, 2022, Kappa Bioscience was acquired by Balchem Corporation. Use the CB Insights Platform to explore Kappa Bioscience's full profile.See details»
Better & healthier with pure vitamin K2 MK-7 | Kappa
About Kappa. Kappa Bioscience AS was founded in Oslo, Norway, in 2006 when a brilliant scientist discovered the synthesis of pure, all-bioactive vitamin K2 MK-7.See details»
Kappa Bioscience - NutraIngredients-USA
Kappa Bioscience ® AS is a leading manufacturer of pure, all-bioactive vitamin K2 MK-7 under the K2VITAL ® brand, the reference standard for the United States Pharmacopeia - used …See details»
KAPPA BIOSCIENCE ANNOUNCES THE FORMATION OF A BLUE …
OSLO, Norway, March 1, 2022 /PRNewswire/ -- Kappa Bioscience (www.kappabio.com), the leading manufacturer of Vitamin K2 under the brand name K2VITAL® announced today the …See details»
Kappa Bioscience AS (@Kappabio) / Twitter
Apr 22, 2015 Producer of K2VITAL® (K2 MK-7). Offering ingredients & services related to bone & heart health, multivitamins. Primary products: K2, D3 & plant-derived Ca CAS®.See details»
Kappa Bioscience announces the formation of SMAB
Kappa Bioscience (www.kappabio.com), the leading manufacturer of Vitamin K2 under the brand name K2VITAL® announced today the formation of a “Blue Ribbon” Scientific and Medical …See details»
News Archive - Kappa Bio
Jun 15, 2022 Norwegian Contract Research Organization Synthetica becomes Kappa Solutions as of November 2021 November 3, 2021 The Kappa Bioscience Group introduces Kappa …See details»
Balchem acquires vitamin K2 specialist Kappa Bioscience eyeing …
15 Jun 2022 --- US-based Balchem is acquiring Norwegian Kappa Bioscience from Verdane Edda for 3.175B NOK (US$338 million – at the time of the acquisition). A definite agreement …See details»
Balchem Corporation completes acquisition of Kappa Bioscience AS
Kappa Bioscience® (www.kappabio.com), the leading manufacturer of Vitamin K2 under the brand name K2VITAL®, announces that the previously announced acquisition from Balchem …See details»
Balchem Corporation Completes Acquisition of Kappa Bioscience AS
Jun 21, 2022 Balchem Corporation announced that it completed its acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human …See details»
Kappa Mission & Vision – Doing it right | Kappa
About Kappa. Kappa Bioscience AS was founded in Oslo, Norway, in 2006 when a brilliant scientist discovered the synthesis of pure, all-bioactive vitamin K2 MK-7.See details»
Balchem Corporation Completes Acquisition of Kappa
NEW HAMPTON, N.Y., June 21, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, …See details»
Experts creating synthetic vitamin K2 | Kappa
The demand for custom-made molecules and label claims control is growing, so we’re always growing our offering to stay ahead. That’s why we offer our partners a completely integrated …See details»